Back to Stakeholders
Categories

1 domain / 2 areas / 1 specialization

Research, Drug Development & Manufacturing
Real-World Data & Evidence CollectionPost-Market Safety Registries
Research, Drug Development & Manufacturing

EMA EudraVigilance

Also known as: European Medicines Agency EudraVigilance

European pharmacovigilance system for suspected adverse drug reaction reporting. Psychedelic relevance: EMA has hosted a multi-stakeholder psychedelics regulatory workshop and EudraVigilance is the key EU safety channel.

Real-World Data Snapshot

Verified

Verification

Verified

Coverage

Global

Access Model

Open access

Last Verified

Apr 7, 2026

Methodology

EudraVigilance aggregates suspected adverse reaction reports for medicines in the EEA and publishes public views through adrreports.eu with standard pharmacovigilance caveats.

Safety monitoring registriesWeeklySafety surveillance data

Primary Dataset

Browse ADR Reports (EU)

Source Evidence

3 sources

EudraVigilance System Overview

https://www.ema.europa.eu/en/human-regulatory-overview/research-development/pharmacovigilance-research-development/eudravigilance/eudravigilance-system-overview

ADR Reports (Public EudraVigilance Portal)

https://www.adrreports.eu/

EMA Psychedelics Regulatory Workshop

https://www.ema.europa.eu/en/events/ema-multi-stakeholder-workshop-psychedelics-towards-eu-regulatory-framework

Quick Facts

Website
Visit